Denise C. Connolly Women's Cancer Program Fox Chase Cancer Center Biography Publications Institution JoVE Articles Denise C. Connolly has not added a biography. If you are Denise C. Connolly and would like to personalize this page please email our Author Liaison for assistance. Publications Miscommunication Involving 'standard Care'. Response to Protocol Review Scenario: Specify All Medications Lab Animal. Mar, 2011 | Pubmed ID: 21326182 Development of a Syngeneic Mouse Model of Epithelial Ovarian Cancer Journal of Ovarian Research. 2010 | Pubmed ID: 20958993 Strategies for High-resolution Imaging of Epithelial Ovarian Cancer by Laparoscopic Nonlinear Microscopy Translational Oncology. 2010 | Pubmed ID: 20563260 Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers PloS One. 2010 | Pubmed ID: 20422001 Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non-invasive Imaging Modalities to Monitor Ovarian Tumor Growth in Situ: Applications in Evaluating Novel Therapeutic Agents Current Protocols in Pharmacology / Editorial Board, S.J. Enna (editor-in-chief) ... [et Al.]. Jun, 2009 | Pubmed ID: 22294392 Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non Invasive Imaging Modalities to Monitor Ovarian Tumor Growth In Situ -Applications in Evaluating Novel Therapeutic Agents Current Protocols in Pharmacology / Editorial Board, S.J. Enna (editor-in-chief) ... [et Al.]. Jun, 2009 | Pubmed ID: 20634901 Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and P53 PloS One. 2009 | Pubmed ID: 20046879 Animal Models of Ovarian Cancer Cancer Treatment and Research. 2009 | Pubmed ID: 19763445 NEDD9 Promotes Oncogenic Signaling in Mammary Tumor Development Cancer Research. Sep, 2009 | Pubmed ID: 19738060 Expression of Activated PIK3CA in Ovarian Surface Epithelium Results in Hyperplasia but Not Tumor Formation PloS One. 2009 | Pubmed ID: 19172191 Magnetic Resonance Imaging for Detection and Determination of Tumor Volume in a Genetically Engineered Mouse Model of Ovarian Cancer Cancer Biology & Therapy. Nov, 2007 | Pubmed ID: 17986851 RAD001 (Everolimus) Delays Tumor Onset and Progression in a Transgenic Mouse Model of Ovarian Cancer Cancer Research. Mar, 2007 | Pubmed ID: 17363557 Mullerian Inhibiting Substance Enhances Subclinical Doses of Chemotherapeutic Agents to Inhibit Human and Mouse Ovarian Cancer Proceedings of the National Academy of Sciences of the United States of America. Nov, 2006 | Pubmed ID: 17088539 Recombinant Human Mullerian Inhibiting Substance Inhibits Long-term Growth of MIS Type II Receptor-directed Transgenic Mouse Ovarian Cancers in Vivo Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2006 | Pubmed ID: 16533786 Cyclooxygenase-1 is Overexpressed in Multiple Genetically Engineered Mouse Models of Epithelial Ovarian Cancer Cancer Research. Mar, 2006 | Pubmed ID: 16510568 Pathology of Ovarian Neoplasms in Genetically Modified Mice Comparative Medicine. Feb, 2004 | Pubmed ID: 15382342 Membrane Localization of V-ErbB is Required but Not Sufficient for Ligand-independent Transformation Experimental Cell Research. Jun, 2004 | Pubmed ID: 15149858 Focus on Epithelial Ovarian Cancer Cancer Cell. Jan, 2004 | Pubmed ID: 14749123 Female Mice Chimeric for Expression of the Simian Virus 40 TAg Under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer Cancer Research. Mar, 2003 | Pubmed ID: 12649204 Activation of Cancer-specific Gene Expression by the Survivin Promoter Journal of the National Cancer Institute. Apr, 2002 | Pubmed ID: 11929953 An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses Selene Nunez-Cruz1, Denise C. Connolly2, Nathalie Scholler1 1Penn Ovarian Cancer Research Center, Center for Research on Reproduction and Womans Health, Department of Obstetrics and Gynecology, University of Pennsylvania-School of Medicine, 2Women's Cancer Program, Fox Chase Cancer Center JoVE 2146 Immunology and Infection
An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses Selene Nunez-Cruz1, Denise C. Connolly2, Nathalie Scholler1 1Penn Ovarian Cancer Research Center, Center for Research on Reproduction and Womans Health, Department of Obstetrics and Gynecology, University of Pennsylvania-School of Medicine, 2Women's Cancer Program, Fox Chase Cancer Center JoVE 2146 Immunology and Infection
